FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
-6.61%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$165M
AUM Growth
+$165M
(-0.06%)
Cap. Flow
+$44.9M
Cap. Flow
% of AUM
27.21%
Top 10 Holdings %
Top 10 Hldgs %
86.73%
Holding
18
New
3
Increased
9
Reduced
1
Closed
4
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$12.5M |
| 2 |
Amicus Therapeutics
FOLD
|
$12.4M |
| 3 |
Axsome Therapeutics
AXSM
|
$11.2M |
| 4 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$7.35M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$3.71M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$4.13M |
| 2 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$3.77M |
| 3 |
XENT
Intersect ENT, Inc
XENT
|
$2M |
| 4 |
argenx
ARGX
|
$198K |
| 5 |
Protara Therapeutics
TARA
|
$140K |
Sector Composition
| 1 | Healthcare | 95.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Acadia Pharmaceuticals
ACAD
$4.38B
| $25.5M | 15.47% | 603,517 +87,729 | +17% | +$3.71M |
|
|
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
| $24M | 14.58% | 971,875 +505,000 | +108% | +$12.5M |
|
3
Insmed
INSM
$28.8B
| $16.4M | 9.92% | 1,020,797 +31,798 | +3% | +$510K |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $14.7M | 8.92% | 491,390 +37,500 | +8% | +$1.12M |
|
|
5
Amicus Therapeutics
FOLD
$2.34B
| $12.4M | 7.51% | +1,340,395 | New | +$12.4M |
|
|
6
Axsome Therapeutics
AXSM
$6.05B
| $11.2M | 6.76% | +189,598 | New | +$11.2M |
|
7
Karyopharm Therapeutics
KPTI
$61.7M
| $10.8M | 6.55% | 562,351 +160,742 | +40% | +$3.09M |
|
|
8
argenx
ARGX
$43.6B
| $10.1M | 6.12% | 76,638 -1,500 | -2% | -$198K |
|
9
Neurogene
NGNE
$264M
| $9.22M | 5.59% | 810,073 | – | – |
|
10
Enanta Pharmaceuticals
ENTA
$180M
| $8.74M | 5.3% | 169,949 +8,000 | +5% | +$411K |
|
|
ALLK
11
DELISTED
Allakos
ALLK
| $7.95M | 4.82% | 178,662 +50,000 | +39% | +$2.22M |
|
|
TRIL
12
DELISTED
Trillium Therapeutics Inc.
TRIL
| $7.35M | 4.45% | +1,818,181 | New | +$7.35M |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $3.49M | 2.11% | 871,714 +30,000 | +4% | +$120K |
|
14
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $3.1M | 1.88% | 200,125 +34,807 | +21% | +$539K |
|
|
ACHN
15
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – | -624,956 | Closed | -$3.77M |
|
|
16
Ascendis Pharma
ASND
$11.8B
| – | – | -29,676 | Closed | -$4.13M |
|
|
17
Protara Therapeutics
TARA
$120M
| – | – | -341,743 | Closed | -$140K |
|
|
XENT
18
DELISTED
Intersect ENT, Inc
XENT
| – | – | -80,238 | Closed | -$2M |
|